1. Behavioral therapy was compared with solifenacin for OAB in PD.
2. Both treatments showed significant symptom improvement after 12 weeks.
3. Dry mouth was more common in the drug group (59%).
4. No falls or adverse effects noted in the behavioral group.
5. Behavioral therapy included pelvic floor training and was administered by trained professionals.
6. The study sample was primarily male, aged 71.3 on average.
7. Findings suggest high adherence to therapy and potential as a first-line treatment.

Source: JAMA Neurology